QC Kinetix Medical Management Team

Physician-Led Clinical Leadership

Advancing responsible regenerative medicine through scientific evaluation, clinical oversight, and continuous improvement.

At QC Kinetix, we believe that responsible medical innovation requires more than the availability of advanced treatment options. It requires experienced physician leadership, rigorous evaluation of scientific evidence, careful assessment of medical technologies, and a commitment to understanding patient outcomes.

The QC Kinetix Medical Management Team (MMT) is a multidisciplinary, physician-led body that guides the medical aspects of the QC Kinetix network. Its physicians bring backgrounds in orthopedic surgery, sports medicine, family medicine, internal medicine, musculoskeletal care, and regenerative medicine. The team also examines emerging scientific literature, evaluates new treatment approaches, and reviews clinical outcomes data to identify opportunities for improvement.

Our guiding philosophy is that clinical decisions should be informed by the best available evidence, sound medical judgment, and the individual needs of each patient.

Our Medical Leadership

The QC Kinetix clinical leadership structure brings together physicians, scientific and technical advisors, and clinical operations professionals. These groups contribute complementary expertise to the evaluation, development, and implementation of clinical practices.

1. Physician Medical Management Team

Clinical experience. Independent medical judgment. Collaborative leadership.

The physician members draw on their specialties to evaluate treatment protocols, assess new technologies, interpret emerging research, and review patient outcomes. Their varied perspectives encourage candid discussion of the benefits, limitations, and appropriateness of regenerative and nonsurgical musculoskeletal treatments.

Physician Members

2. Scientific and Technical Advisory Support

Scientific and Technical Advisor

Theodore Sand, PhD
Biotechnology and Regenerative Medicine Senior Consultant

Evaluating the science and technology behind clinical care.

The MMT draws on expertise in biotechnology, laboratory science, device performance, regulatory compliance, and product quality to evaluate regenerative medicine technologies, biologic preparation systems, and emerging clinical innovations.

The MMT’s scientific and technical reviews address device specifications, preparation methodologies, platelet recovery and concentration, cellular characteristics, sterility considerations, manufacturer documentation, and the strength of available supporting evidence.

The purpose of this evaluation is to help ensure that clinical technology decisions are grounded in appropriate scientific and technical considerations.

3. Clinical Operations and Implementation

Clinical Operations Leadership

Ginger Arntz, MSN, FNP-C

Connecting medical guidance with clinical practice.

Clinical operations connect physician leadership with clinicians across the network – communicating medical guidance, supporting provider education and procedural documentation, and integrating approved practices. It also reports back to medical leadership on workflows, training needs, and opportunities for quality improvement.

Medical decisions remain the responsibility of appropriately licensed healthcare professionals exercising independent clinical judgment.

What the Medical Management Team Does

Clinical Oversight and Scientific Review

The Medical Management Team evaluates the medical and scientific foundations of QC Kinetix’s clinical programs, while also assessing operational considerations.

Its work encompasses six interconnected areas of responsibility.

The MMT evaluates the protocols used across the network – including patient selection, treatment indications, procedural techniques, treatment sequencing, follow-up, and documentation – to confirm they remain consistent with current evidence, clinical experience, and appropriate medical standards, and refines them when new information warrants.  Each local professional entity and treating clinician retains authority over clinical policies and individual care decisions—including whether guidance is appropriate for a patient.

1. Clinical Protocol Development and Evaluation Read Less

The MMT reviews medical devices, preparation systems, and clinical technologies under consideration for use within the network.

Evaluations may include:

  • Device design, technical specifications, and performance characteristics
  • Platelet concentration, platelet recovery, and preparation consistency
  • Plasma and cellular preparation methodologies
  • Product sterility, quality control, and handling requirements
  • FDA regulatory status, intended use, and applicable labeling
  • Manufacturer documentation and available supporting studies
  • Clinical suitability, procedural compatibility, and practical implementation

The MMT seeks to distinguish clinically meaningful technological advances from unsupported or inadequately substantiated product claims.

2. Medical Device and Biologic Preparation Technology Assessment Read Less

The MMT supports systematic review of patient-reported outcomes – such as changes in pain, physical function, and satisfaction – to identify trends and refine protocols and patient selection. The goal is not simply to measure outcomes, but to use them responsibly to improve care (see Clinical Outcomes and Continuous Improvement below).

3. Patient Outcomes Collection and Analysis Read Less

Regenerative medicine is an evolving field. The MMT reviews published research on the treatments and technologies QC Kinetix uses or is considering, including platelet-rich plasma, plasma protein-based preparations, bone marrow-derived treatments, orthobiologics, image-guided interventions, and complementary nonsurgical technologies.

The team weighs study methodology, sample size, clinical relevance, reproducibility, and safety findings, recognizing that promising early results do not by themselves establish effectiveness.

4. Scientific Literature and Emerging Research Read Less

The MMT reviews the medical aspects of clinical operations with a focus on patient safety and appropriate care – including patient eligibility, informed consent, procedural standards, documentation, product handling, adverse events, follow-up, and regulatory requirements.

The aim is consistent clinical standards that preserve the independent judgment of each treating professional.

5. Clinical Quality, Patient Safety, and Medical Standards Read Less

The MMT supports ongoing education and collaboration across the network. Drawing on its members’ diverse backgrounds, the team shares emerging evidence, protocols, techniques, and practical clinical experience to promote informed decision-making and professional development.

6. Provider Education and Professional Collaboration Read Less
  1. Clinical Protocol Development and Evaluation

The MMT evaluates the protocols used across the network – including patient selection, treatment indications, procedural techniques, treatment sequencing, follow-up, and documentation – to confirm they remain consistent with current evidence, clinical experience, and appropriate medical standards, and refines them when new information warrants.  Each local professional entity and treating clinician retains authority over clinical policies and individual care decisions—including whether guidance is appropriate for a patient.

  1. Medical Device and Biologic Preparation Technology Assessment

The MMT reviews medical devices, preparation systems, and clinical technologies under consideration for use within the network.

Evaluations may include:

  • Device design, technical specifications, and performance characteristics
  • Platelet concentration, platelet recovery, and preparation consistency
  • Plasma and cellular preparation methodologies
  • Product sterility, quality control, and handling requirements
  • FDA regulatory status, intended use, and applicable labeling
  • Manufacturer documentation and available supporting studies
  • Clinical suitability, procedural compatibility, and practical implementation

The MMT seeks to distinguish clinically meaningful technological advances from unsupported or inadequately substantiated product claims.

  1. Patient Outcomes Collection and Analysis

The MMT supports systematic review of patient-reported outcomes – such as changes in pain, physical function, and satisfaction – to identify trends and refine protocols and patient selection. The goal is not simply to measure outcomes, but to use them responsibly to improve care (see Clinical Outcomes and Continuous Improvement below).

  1. Scientific Literature and Emerging Research

Regenerative medicine is an evolving field. The MMT reviews published research on the treatments and technologies QC Kinetix uses or is considering, including platelet-rich plasma, plasma protein-based preparations, bone marrow-derived treatments, orthobiologics, image-guided interventions, and complementary nonsurgical technologies.

The team weighs study methodology, sample size, clinical relevance, reproducibility, and safety findings, recognizing that promising early results do not by themselves establish effectiveness.

  1. Clinical Quality, Patient Safety, and Medical Standards

The MMT reviews the medical aspects of clinical operations with a focus on patient safety and appropriate care – including patient eligibility, informed consent, procedural standards, documentation, product handling, adverse events, follow-up, and regulatory requirements.

The aim is consistent clinical standards that preserve the independent judgment of each treating professional.

  1. Provider Education and Professional Collaboration

The MMT supports ongoing education and collaboration across the network. Drawing on its members’ diverse backgrounds, the team shares emerging evidence, protocols, techniques, and practical clinical experience to promote informed decision-making and professional development.

Our Approach to Clinical Evidence

Scientific Evaluation Is an Ongoing Responsibility

Medical knowledge evolves, and any treatment or technology that looks promising today must remain open to critical evaluation as new evidence emerges. The team asks six questions of every clinical practice and innovation:

No single protocol, product, or technology is assumed to be a permanent or universal solution. Responsible innovation requires both openness to new possibilities and a willingness to question the evidence behind them.

Person on snowboard overlooking mountains

Clinical Outcomes and Continuous Improvement

Learning From Patient Experiences

Patient-reported outcomes offer valuable insight into changes in pain, physical function, satisfaction, and the experience of care over time. The MMT reviews and interprets this information to better understand treatment experiences and identify opportunities for improvement.

Our Outcomes Assessment Priorities

Meaningful patient measures
Evaluating patient-reported changes in pain, function, and other relevant aspects of musculoskeletal health.

Longitudinal follow-up
Examining outcomes at different time points to better understand patient-reported experiences beyond the immediate treatment period.

Clinical interpretation
Considering patient characteristics, treatment differences, follow-up rates, and other factors that may influence reported results.

Continuous improvement
Using findings to inform discussions about clinical protocols, patient selection, provider education, and future quality initiatives.

Transparency in Outcomes Reporting
Outcomes information must be presented in context. Observational data can offer useful insight, but cannot by themselves establish that a treatment caused an improvement; incomplete follow-up, selection bias, differences among patients, and the absence of randomized comparison groups all affect interpretation.

QC Kinetix distinguishes patient-reported observations from conclusions established through controlled clinical research.

Our Commitment to Responsible Regenerative Medicine

Meaningful progress in regenerative medicine depends on physician leadership, careful evaluation, professional accountability, and a willingness to refine clinical practice as knowledge advances.

Through collaboration among physicians, scientific advisors, and clinical operations professionals, the QC Kinetix Medical Management Team is committed to responsible innovation, evidence-informed medicine, and continuous improvement in the care of patients with musculoskeletal conditions.

Our commitment is to responsible innovation, evidence-informed medicine, and continuous improvement in the care of patients with musculoskeletal conditions.

Contact Us

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
Chosen Location
Secret Link